Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 13, 2026
United States Antimony (UAMY) Slides -16.75% in 30 Days Following Earnings Miss

United States Antimony (UAMY) Slides -16.75% in 30 Days Following Earnings Miss

Key Takeaways

  • UAMY fell about 16.75% over the 30-day window ended with the latest available close, from $5.97 to $4.97.
  • The decline was driven by second-quarter 2026 results released August 11: revenue of $7.9 million, down 25% year over year and below consensus expectations.
  • Full-year 2026 revenue guidance was reduced to $60 million–$75 million from a prior target of $125 million.
  • The average antimony selling price fell about 52% year over year, compressing gross margin to roughly 7% from 27%, even as pounds sold rose 26%.
  • Offsetting positives include zeolite revenue up 110%, $62.2 million in cash and U.S. Treasuries, and approximately $57.3 million in cumulative DLA contract orders.

Company Background and Position in Critical Minerals

United States Antimony Corporation operates as a fully integrated producer of critical minerals, handling mining, milling, processing, and sales of antimony products, zeolite, and precious metals. Its U.S. facilities include the Thompson Falls smelter in Montana and the Radersburg flotation mill, along with development projects in Alaska, Idaho, and Bolivia. Antimony finds use in flame retardants, batteries, alloys, and defense applications, positioning the company as a notable domestic player in the U.S. critical-minerals supply chain. It serves industrial, agricultural, and government customers, including through deliveries under a Defense Logistics Agency contract.

Recent Stock Performance Over 30 Days and the Quarter

Over the 30-day window, UAMY moved from a July 13, 2026 close of $5.97 down to $4.97 at the latest available close, for a decline of 16.75%. Much of that move occurred on August 12, when shares dropped roughly 24.5% from $6.58 to $4.97 following the earnings release—the largest single-session decline in more than nine months. Looking further back, the stock is down about 48% from its May 14 close of $9.57, reflecting a broader downtrend that began after early May.

What Moved the Stock in the Latest 30 Days

The primary catalyst was the second-quarter 2026 earnings report released after the close on August 11, 2026. Revenue totaled $7.9 million, down 25% from $10.5 million in the year-earlier period and below consensus estimates. While antimony pounds sold rose 26% to approximately 428,425, the average selling price fell about 52% to $13.70 per pound. That price compression pushed gross margin down to roughly 7% from 27% in the prior-year quarter. The company reported an operating loss of about $7 million and lowered its full-year 2026 revenue guidance to a range of $60 million to $75 million.

H.C. Wainwright kept its Buy rating but reduced the price target to $9.25 from $11.75. On the positive side, zeolite revenue climbed 110% to $1.9 million, cash and U.S. Treasuries stood at $62.2 million, working capital reached $70 million, and cumulative DLA orders totaled about $57.3 million. Still, the guidance cut and margin pressure shaped the market’s response. I also checked sector peers using Tickeron’s AI Screener to see how UAMY stacked up on valuation and growth metrics.

Performance Drivers Over the Past Quarter

The three-month decline has largely followed a normalization in antimony prices. Spot prices have moved toward roughly $10 per pound from earlier levels near $28 per pound that had supported higher revenue expectations. Realized selling prices and margins fell faster than volume growth could offset. The company has continued to invest in the Thompson Falls expansion, the Radersburg mill, and projects in Alaska, Idaho, and Bolivia. Equity issuances bolstered the balance sheet but also raised share-based compensation and operating expenses, contributing to a repricing of revenue expectations while domestic capacity builds and DLA deliveries continue.

Factors to Monitor Going Forward

Investors will want to track the pace of revenue recognition from DLA deliveries, including roughly $2.6 million expected in the third quarter after July acceptance, and whether further shipments can support the revised $60 million–$75 million revenue target. Antimony spot pricing remains key, with management noting that prices could stay near $10 per pound for the rest of 2026. Other items to watch include operational milestones at Thompson Falls, Radersburg, and the Alaska, Idaho, and Bolivia projects, continued zeolite volume growth, commodity-price volatility, execution and permitting timelines, potential dilution from equity financing, and U.S. critical-minerals policy developments.

AI Tools in My Research Workflow

In my research process, I frequently consult Tickeron’s Trending AI Robots to see how automated strategies are performing on stocks like this. It helps me gauge sentiment and potential automated trading flows without relying solely on manual charts.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UAMY

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


UAMY's RSI Oscillator recovers from oversold territory

The RSI Oscillator for UAMY moved out of oversold territory on July 17, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on UAMY as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UAMY just turned positive on July 31, 2026. Looking at past instances where UAMY's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where UAMY advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where UAMY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

UAMY moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for UAMY moved below the 200-day moving average on July 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UAMY broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for UAMY entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UAMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.110) is normal, around the industry mean (11.499). P/E Ratio (0.000) is within average values for comparable stocks, (126.632). UAMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.293). UAMY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (18.797) is also within normal values, averaging (280.594).

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Vale SA (NYSE:VALE).

Industry description

The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.

Market Cap

The average market capitalization across the Other Metals/Minerals Industry is 9.33B. The market cap for tickers in the group ranges from 230 to 227.43B. BHP holds the highest valuation in this group at 227.43B. The lowest valued company is BAJFF at 230.

High and low price notable news

The average weekly price growth across all stocks in the Other Metals/Minerals Industry was 5%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was -15%. WWR experienced the highest price growth at 48%, while UAMY experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Other Metals/Minerals Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was -38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 78
Price Growth Rating: 56
SMR Rating: 92
Profit Risk Rating: 86
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
UAMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of antimony products

Industry OtherMetalsMinerals

Profile
Details
Industry
Metal Fabrication
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.